Explore Stanford technologies available for licensing:

Researchers at Stanford have developed a novel endoscopic system for electrical stimulation and signal recording of olfactory tissue through a minimally invasive nasal approach.

Researchers have developed an improved tip-extending soft "vine" robot system that combines inflatable external beams with a novel flanged tip mount design.

Stanford researchers have developed a novel class of fluorescent RNA-selective "RiboLight" dyes which enables bright, covalent, and highly specific labeling of RNA without DNA interference, delivering superior performance for imaging and quantification applications.

Disease indication - Type 1 and Type 2 Diabetes

Drug format - Peptide hormones (combination of amylin analogues and insulin analogues)

Drug class - Novel formulation with designer excipient for improved/simplified delivery

Stanford researchers have developed a novel inhibitor-based conditioning regimen that safely and effectively induces immune tolerance.

Stanford researchers have created the orthoCD3 T cells, by engineering T cells to resist depletion from anti-CD3 antibodies during lymphodepletion, thereby, enhancing the efficacy of T cell therapies for cancer, autoimmune disorders, and transplant rejection.

The limited duration of humoral responses to vaccination is a key issue in the fight against infectious diseases, as antibody levels wane over time, leaving individuals vulnerable to reinfection.

Stanford researchers in the Montine Lab have created novel indolinone LRRK2 kinase inhibitors, a class of compounds for treating disorders associated with LRRK2, including Parkinson's disease, cancer, leprosy, Alzheimer's disease, other neurodegenerative diseases, and immune-m

Stanford scientists have developed a cell-free method for producing high-purity plasmid DNA without the use of bacterial hosts. This approach eliminates contamination risks, reduces production time, and streamlines manufacturing for gene and cell therapies.

Stanford researchers have developed a new software platform that transforms clinical ambulatory cardiac monitoring.

Stanford Medicine researchers in The Stuart Goodman Lab have developed a bone anchor system for surgical tracking that is easier to use and decreases complications caused by conventional knee or hip replacement bone pin anchors.

Stanford Artificial Retina Project researchers have developed an ASIC Retina Chip that interfaces with retinal ganglion cells to restore vision in patients with retinal degeneration.

Stanford researchers in the CHARM Lab have developed a steerable vine robot specifically designed for pipe and burrow environments.

Stanford researchers in the CHARM Lab have developed a steerable vine robot specifically designed for pipe and burrow environments.

Researchers at Stanford and CZ Biohub SF have developed a novel antibody mediated strategy for the treatment of pediatric chronic lung diseases.